Your English writing platform
Discover LudwigExact(1)
The increase in LC3-II accumulation followed a dose response trend (Fig. 1B) and was not associated with cytotoxicity (as measured by MTT assay) in the concentration range of 1 5 μM (Fig. 1C).
Similar(59)
The experimental results indicated that not only the fibrillation of HEWL at high temperature (65 °C) and low pH (pH = 2.0) could be inhibited effectively by N-GQDs, but the inhibition of HEWL by N-GQDs followed a dose-dependent manner.
This difference was small but followed a dose-response pattern.
The range of observed individual measurements of HCQ concentration followed a dose-proportional relationship (Fig. 2B).
The risks of developing prehypertension followed a dose-response relationship for all GGT levels above the first GGT quartile (GGT less than 17 U/L).
Significant increases in VBP15 groups followed a dose-dependent pattern from 14% at 5 mg/kg (p < 0.05) to 20% at 30 mg/kg (p < 0.0005).
The relationship of GGT to MetS followed a dose-response relationship across each of participant quartiles 2 through 4, when compared to the first GGT quartile.
Neuronal death induced by ADDL followed a dose-dependent trend, with notable death at 5 and 10 μM of A β.
This association followed a dose-response pattern for all three classes of study drug and extended beyond the time of use.
Decreases in VBP15 groups followed a dose-dependent pattern, from a 22% decrease in comparison to vehicle at 5 mg/kg to a 41% decrease at 30 mg/kg in hindlimbs.
Similarly, fatal CVD events among women followed a dose-proportion relationship that became significant at GGT levels above 18 U/L with an incremental mortality risk of 35%; at GGT levels between 18 and 26 U/L, increased mortality risk was measured at 46%, and at levels above 36 U/L, it was shown to be 51%.
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com